found that GLP-1 receptor agonist use, compared with initiation of sodium-glucose cotransporter 2 (SGLT2) inhibitors, was associated with a lower risk of composite MALOs (aHR: 0.84, 95%CI: 0.74-0.94), including specifically lower occurrence of liver decompensation (aHR: 0.83) and all-cause mortality (aHR: 0.84) [56]
At TrimRx, we understand that the search for affordable, science-backed weight management can feel like navigating a maze
Safrany ST, Brimson JM
In human studies, daily doses of 412mg have been associated with improvements in skin moisture, elasticity, and barrier function over 812 weeks, with more mixed results for wrinkle depth.1 25 People with digital eye strain Athletes or active individuals Adults seeking metabolic and cardiovascular support Astaxanthins antioxidant and mitochondrial effects may also provide modest benefits to heart and metabolic function
The combination of redox buffering and inflammatory damping is a recurring theme across the compound's reported applications